WA
BIO icon

WPG Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History

WPG Advisers’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.05K Hold
24
– – ﹤0.01% 880
2026
Q1 		$6.69K Buy
24
+1
+4% +$288 ﹤0.01% 801
2025
Q4 		$6.97K Hold
23
– – 0.01% 810
2025
Q3 		$6.45K Buy
23
+1
+5% +$272 0.01% 826
2025
Q2 		$5.31K Sell
22
-1
-4% -$236 ﹤0.01% 860
2025
Q1 		$5.6K Buy
23
+8
+53% +$2.41K 0.01% 844
2024
Q4 		$4.93K Buy
+15
New +$5.09K ﹤0.01% 822

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

WPG Advisers's BIO Position: Q2 2026 in Review

WPG Advisers held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 24 shares worth $7.05K. The position accounts for ﹤0.01% of the portfolio, ranked #880.

WPG Advisers first reported a position in BIO in Q4 2024 and has held it in 7 quarters since. 181 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • WPG Advisers held 24 shares of Bio-Rad Laboratories Class A worth $7.05K as of Q2 2026.
  • WPG Advisers left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #880 holding.
  • WPG Advisers first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 7 quarters since.
  • 181 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.